CD8A and neoplasm: ICB effectiveness can be affected by the degree of CD8+ T cell infiltration (50), mutation or neo-antigen load (23), PD-L1 level (51), antigen presentation defects (52), interferon signaling (53), mismatch repair defIciency (54), tumor aneuploidy (55) and intestinal microbiota (56).